(NaturalNews) Pfizer and BioNTech abruptly halted a major U.S. trial for their updated COVID-19 booster in healthy adults aged 50-64 due to failed enrollment, r…
Pfizer and BioNTech end key COVID-19 vaccine trial in the United States
Estimated read time
1 min read
